NINDS Neuroscience Funding Announcements

Countermeasures against Chemical Threats (Counteract) Preclinical Development Facility

Funding Contact(s): Helene Braun
Funding Categories: Translational Research

Brief Description:
The overall goal of this research program is to enhance our diagnostic and treatment response capabilities during an emergency. The NIH requires a nontraditional, proactive, and product development oriented program to provide preclinical development support for promising therapeutic candidates. The Preclinical Development Facility will be part of a comprehensive research network and is designed to support a centralized facility for the advanced preclinical development of promising candidate pharmaceutical preparations.

NIH Guide: NOT-NS-06-006
Release Date: 2006-03-27
Expiration Date: 2006-05-31